Pharmacotherapy of traumatic brain injury: state of the science and the road forward: report of the Department of Defense Neurotrauma Pharmacology Workgroup.
about
Progesterone for Acute Traumatic Brain Injury: A Systematic Review of Randomized Controlled TrialsCathepsin B is a New Drug Target for Traumatic Brain Injury Therapeutics: Evidence for E64d as a Promising Lead Drug CandidateBench-to-Bedside and Bedside Back to the Bench; Seeking a Better Understanding of the Acute Pathophysiological Process in Severe Traumatic Brain InjuryThe promotion of recovery through rehabilitation after acquired brain injury in childrenNonsurgical therapy for hydrocephalus: a comprehensive and critical reviewEmerging therapies in traumatic brain injuryInhibition of Eukaryotic Initiation Factor 2 Alpha Phosphatase Reduces Tissue Damage and Improves Learning and Memory after Experimental Traumatic Brain InjuryCognitive Impairments Induced by Concussive Mild Traumatic Brain Injury in Mouse Are Ameliorated by Treatment with Phenserine via Multiple Non-Cholinergic and Cholinergic MechanismsFDG-PET imaging in mild traumatic brain injury: a critical review.What's New in Traumatic Brain Injury: Update on Tracking, Monitoring and TreatmentAcute administration of catalase targeted to ICAM-1 attenuates neuropathology in experimental traumatic brain injury.Selective vasopressin-1a receptor antagonist prevents brain edema, reduces astrocytic cell swelling and GFAP, V1aR and AQP4 expression after focal traumatic brain injury.Transiently lowering tumor necrosis factor-α synthesis ameliorates neuronal cell loss and cognitive impairments induced by minimal traumatic brain injury in miceFailure of intravenous or intracardiac delivery of mesenchymal stromal cells to improve outcomes after focal traumatic brain injury in the female rat.Phenotypic assays to identify agents that induce reactive gliosis: a counter-screen to prioritize compounds for preclinical animal studiesSerum SNTF Increases in Concussed Professional Ice Hockey Players and Relates to the Severity of Postconcussion Symptoms.Brain Recovery after a Plane Crash: Treatment with Growth Hormone (GH) and Neurorehabilitation: A Case Report.Combination Therapies for Traumatic Brain Injury: Retrospective ConsiderationsCirculating Brain-Derived Neurotrophic Factor Has Diagnostic and Prognostic Value in Traumatic Brain Injury.Neurorestoration after traumatic brain injury through angiotensin II receptor blockageMagnesium sulfate treatment for juvenile ferrets following induction of hydrocephalus with kaolin.Serum Concentrations of Ubiquitin C-Terminal Hydrolase-L1 and Glial Fibrillary Acidic Protein after Pediatric Traumatic Brain InjuryNeuroprotective levels of IGF-1 exacerbate epileptogenesis after brain injury.Neuroprotective effects of estrogen in CNS injuries: insights from animal modelsABCG2 c.421C>A is Associated with Outcomes Following Severe Traumatic Brain Injury.Concussions, Traumatic Brain Injury, and the Innovative Use of Omega-3s.Peptide Pharmacological Approaches to Treating Traumatic Brain Injury: a Case for Arginine-Rich Peptides.The use of antioxidants in the treatment of traumatic brain injury.Aquaporins in Brain Edema and Neuropathological Conditions.Hypoxia inducible factor-1 alpha stabilization for regenerative therapy in traumatic brain injury.Post-traumatic administration of the p53 inactivator pifithrin-α oxygen analogue reduces hippocampal neuronal loss and improves cognitive deficits after experimental traumatic brain injury.Analysis of Post-Traumatic Brain Injury Gene Expression Signature Reveals Tubulins, Nfe2l2, Nfkb, Cd44, and S100a4 as Treatment Targets.Rethinking Neuroprotection in Severe Traumatic Brain Injury: Toward Bedside NeuroprotectionRepositioning drugs for traumatic brain injury - N-acetyl cysteine and PhenserineBridging the Gap of Standardized Animals Models for Blast Neurotrauma: Methodology for Appropriate Experimental Testing.Protein Biomarkers and Neuroproteomics Characterization of Microvesicles/Exosomes from Human Cerebrospinal Fluid Following Traumatic Brain Injury.Rodent Models of Traumatic Brain Injury: Methods and Challenges.Effect of Intermediate-Frequency Repetitive Transcranial Magnetic Stimulation on Recovery following Traumatic Brain Injury in Rats.Erythropoietin Attenuates the Brain Edema Response after Experimental Traumatic Brain Injury.Is temperature an important variable in recovery after mild traumatic brain injury?
P2860
Q24288649-A83857FF-CD92-47CC-89BA-9AC98373DA03Q26782938-DE5392F3-237F-4653-9858-389E2A29D283Q26823369-55703649-97F8-4917-909D-FFF9034DE633Q27012588-8C57309A-470C-427D-ACF5-6A9C638327B8Q28079392-84DAC4FC-D0FD-4C1E-8170-0965862F66B0Q28087789-8AB85880-F77D-4C57-B50F-3DD7252B8728Q28390392-85B27E1C-D835-4C24-A708-AF0B9E58189AQ28552599-E2FDC85E-C3C7-4F53-AFDC-38FB197B9550Q30730474-F2C23978-816F-4D54-BFE7-015BB81D21C6Q30959630-F448450A-3F33-4734-A782-CF0C067FB12BQ33812816-E9AB4816-3DEF-447E-8C74-6C462E5C5D47Q34554602-D480DA99-E9B1-4D84-A53D-3752903934D2Q35155498-39CB3C96-B4FD-45D3-9E90-594BB2399063Q35577615-928C8B73-FB21-47D9-9E53-1BACB2A8DD73Q35729506-D92B9F09-9E7A-4A38-9D1C-9A7940FC3756Q35977643-F979F116-1BF2-490B-8E46-D873F1795DA3Q36404372-51E44B93-4D22-4358-8F5D-03928194F3ABQ36427698-5D6775E2-B4BF-4756-A240-991829ECBA71Q36489519-979B4ABD-A8F1-4D8D-A2C1-EA0620B37A2EQ36515931-C51B5089-0C2D-490F-B57A-36416BE79692Q36846772-A201D070-22A6-44C1-AE77-A0C781214497Q37019440-451FA5A3-7428-47ED-A8CB-EB9CFD3EF553Q37208889-E53EF47D-6EC8-49C4-BE3F-F3703083D9FDQ38636826-0F7956CF-D57A-4A62-A5B5-AA7B0122F45FQ38651433-31B1977D-4171-4230-AC81-8A177ADC1CA7Q38907714-B5A2164D-75A5-4F33-85A2-0089A62D648AQ39008879-5FA42D94-C1A0-4A79-A2A7-A6797B3EFE64Q39012345-5A46CCDB-DBBC-48BC-BDB8-484D309C5EE3Q39063020-A4DB9D1E-5B25-4EB0-AD18-B9D4068B075EQ39374463-1EEF543A-9239-46DB-A0C5-D0B8184E55BBQ39461208-3C868B07-057B-4F6D-A19D-2C39075DC158Q39484563-CF6FBD3A-0FE4-428A-B5AF-748FEFA0E025Q41102255-5AD8CFFD-B824-4063-BF8E-D864DD797ECAQ41467872-73F7BE34-CE4D-4AED-8D3D-5F6C8D5EE24BQ45041965-713B0AC4-01C1-4F12-A16E-90CEBB3A0C01Q46172024-71EAD009-BA2C-4ED8-BFE8-A3382E939E03Q46492392-4A67C3D9-103C-47B7-BD24-9546EDD4815EQ47213513-6C6FD1B3-3976-4EED-A2CB-BF937575AFCFQ47360067-21445CDB-D791-4C47-A03E-01E3EBE58E50Q47389691-5D93B255-88B9-41E1-A0B9-9896367554E7
P2860
Pharmacotherapy of traumatic brain injury: state of the science and the road forward: report of the Department of Defense Neurotrauma Pharmacology Workgroup.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pharmacotherapy of traumatic b ...... trauma Pharmacology Workgroup.
@en
Pharmacotherapy of traumatic b ...... trauma Pharmacology Workgroup.
@nl
type
label
Pharmacotherapy of traumatic b ...... trauma Pharmacology Workgroup.
@en
Pharmacotherapy of traumatic b ...... trauma Pharmacology Workgroup.
@nl
prefLabel
Pharmacotherapy of traumatic b ...... trauma Pharmacology Workgroup.
@en
Pharmacotherapy of traumatic b ...... trauma Pharmacology Workgroup.
@nl
P2093
P2860
P50
P921
P356
P1476
Pharmacotherapy of traumatic b ...... trauma Pharmacology Workgroup.
@en
P2093
Christine E Marx
Col Jamie B Grimes
Devon Oskvig
Kenneth C Curley
Kimbra Kenney
L T C Gina E Adam
L T C Yince Loh
Wanda Salzer
P2860
P304
P356
10.1089/NEU.2013.3019
P577
2014-01-01T00:00:00Z